Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01DJI
|
|||
| Former ID |
DIB001136
|
|||
| Drug Name |
PHY-906
|
|||
| Indication | Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0; ICD-9: 155] | Phase 2 | [1] | |
| Company |
PhytoCeutica Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer. Cancer Chemother Pharmacol. 2014 Feb;73(2):373-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.